STAA Staar Surgical Co

  1. Stocks
  2. Healthcare
  3. NASDAQ: STAA

Price (delayed)

$24.94

Market cap

$1.25B

P/E Ratio

311.75

Dividend/share

N/A

EPS

$0.08

Enterprise value

$1.14B

?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 62
Relative Valuation: Rel. Valuation: 17
Relative Profitability: Rel. Profitability: 65

STAAR Surgical is the global leader in implantable phakic intraocular lenses, a vision correction solution that reduces or eliminates the need for glasses or contact lenses. Since 1982, STAAR has ...

Highlights
Staar Surgical's EPS has surged by 119% QoQ and by 104% YoY
Staar Surgical's net income has soared by 118% from the previous quarter and by 104% YoY
STAA's quick ratio is down by 5% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.staar.com
Peers: COO ABT IRIX NVS

Key stats

What are the main financial stats of STAA

STAA stock price

How has the Staar Surgical stock price performed over time
Intraday
1.63%
1 week
7.36%
1 month
10.99%
1 year
-3.59%
YTD
8.01%
QTD
10.31%

Financial performance

How have Staar Surgical's revenue and profit performed over time
Revenue
$339.59M
Gross profit
$260.2M
Operating income
$13.73M
Net income
$3.84M
Gross margin
76.6%
Net margin
1.1%
STAA's operating income has surged by 152% since the previous quarter and by 113% year-on-year
Staar Surgical's operating margin has soared by 144% from the previous quarter and by 108% YoY
Staar Surgical's net income has soared by 118% from the previous quarter and by 104% YoY
Staar Surgical's net margin has soared by 115% from the previous quarter and by 103% YoY

Price vs fundamentals

How does STAA's price correlate with its fundamentals

Growth

What is Staar Surgical's growth rate over time

Valuation

What is Staar Surgical stock price valuation
STAA P/E details
P/E
311.75
P/B
3.4
P/S
3.7
EV/EBIT
65.47
EV/EBITDA
36.92
EV/Sales
3.35
Staar Surgical's EPS has surged by 119% QoQ and by 104% YoY
STAA's price to book (P/B) is 47% lower than its 5-year quarterly average of 6.4
Staar Surgical's equity has increased by 9% YoY and by 3.7% QoQ
The stock's price to sales (P/S) is 51% less than its 5-year quarterly average of 7.6 and 20% less than its last 4 quarters average of 4.6
The revenue has soared by 51% YoY and by 17% from the previous quarter

Efficiency

How efficient is Staar Surgical business performance
The ROIC has soared by 188% from the previous quarter and by 121% YoY
Staar Surgical's return on sales has surged by 176% QoQ and by 112% YoY
The ROE has soared by 118% from the previous quarter and by 104% YoY
Staar Surgical's return on assets has surged by 117% QoQ and by 104% YoY

Dividends

What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STAA.

Financial health

How did Staar Surgical financials performed over time
Staar Surgical's total liabilities has increased by 11% from the previous quarter and by 8% YoY
The current ratio has contracted by 9% from the previous quarter and by 6% YoY
Staar Surgical's debt is 90% less than its equity
The company's debt to equity fell by 17% YoY and by 9% QoQ
Staar Surgical's debt has decreased by 11% YoY and by 3.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.